:COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB
$279,862,800
| Recipient | GLAXOSMITHKLINE, LLC UEI FRHTPHMZMX47 |
|---|---|
| Award ID | W58P0521C0008 |
| Award amount | $279,862,800 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Defense — Department of the Army |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Set-aside | Unrestricted |
| Start date | Sep 24, 2021 |
| End date | May 19, 2022 |
| Place of performance | DURHAM, NC |
| Record updated | Oct 8, 2021 |
View the official award record
More awards won by GLAXOSMITHKLINE, LLC
:COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES
Department of Defense · $1,596,901,996 · Nov 15, 2021
GLAXOSMITHKLINE ADJUVANT AS03
Department of Defense · $346,055,756 · Jul 30, 2020
RELENZA (ZANAMIVIR) ROTADISK, 5MG
Department of Health and Human Services · $45,499,950 · Sep 30, 2025
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5N8) VIRUS VACCINE CANDIDATE AND CLINICAL TRIAL FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ CONTRACT # 75A50122D00002 BASE PERIOD.
Department of Health and Human Services · $22,877,697 · Sep 14, 2022
8508921650!INFLUENZA VIRUS VAC
Department of Defense · $18,846,168 · Aug 31, 2022
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids